PF
Rating #93
Pfizer
Portfolio value
Stocks
Performance
1 Year
+52.13%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 96.24% of the portfolio
Adds
New Buys
Sold Outs
Cuts
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() ORIC | Pharmaceutical Pres | $8.07 | Cut -11.08% | 4.78M | $57.65M | 24.14% 5.55ppt | 5.45% | 6 Quarters | Q1 2026 | |
2 ![]() ALLO | Biological products | $2.13 | 0.00% | 22.03M | $49.79M | 20.85% 8.09ppt | 9.99% | 6 Quarters | Q4 2024 | |
3 ![]() ARVN | Pharmaceutical Pres | $19.17 | 0.00% | 3.46M | $34.92M | 14.63% -2.72ppt | 5.33% | 6 Quarters | Q4 2024 | |
4 ![]() CELC | Medical Laboratories | $13.09 | Cut -15.38% | 295.65K | $31.35M | 13.13% -1.61ppt | 0.56% | 6 Quarters | Q1 2026 | |
5 ![]() ZURA | Biological products | $2.50 | Cut -4.41% | 2.84M | $16.83M | 7.05% 0.47ppt | 3.02% | 6 Quarters | Q1 2026 | |
6 ![]() WVE | Pharmaceutical Pres | $12.37 | 0.00% | 1.88M | $11.93M | 5.00% -8.48ppt | 1.04% | 6 Quarters | Q4 2024 | |
7 ![]() PYXS | Pharmaceutical Pres | $1.56 | 0.00% | 7.03M | $9.21M | 3.86% 0.44ppt | 11.32% | 6 Quarters | Q4 2024 | |
8 ![]() CRBU | Biological products | $1.59 | 0.00% | 4.69M | $8.35M | 3.50% 0.34ppt | 5.02% | 6 Quarters | Q4 2024 | |
9 ![]() SPRO | Pharmaceutical Pres | $1.03 | 0.00% | 2.36M | $5.50M | 2.31% -0.02ppt | 4.22% | 6 Quarters | Q4 2024 | |
10 ![]() BHVN | Pharmaceutical Pres | $37.35 | 0.00% | 505.65K | $4.23M | 1.77% -0.64ppt | 0.42% | 6 Quarters | Q4 2024 | |
11 ![]() CRDF | Biological products | $4.34 | 0.00% | 2.41M | $3.74M | 1.57% -1.30ppt | 3.61% | 6 Quarters | Q4 2024 | |
12 ![]() ZNTL | Pharmaceutical Pres | $3.03 | 0.00% | 953.83K | $2.00M | 0.84% 0.29ppt | 1.33% | 6 Quarters | Q4 2024 | |
13 ![]() NXTC | Pharmaceutical Pres | $5.86 | Cut -2.72% | 153.35K | $1.54M | 0.64% -0.30ppt | 4.37% | 3 Quarters | Q1 2026 | |
14 A AGMB | - | $10.85 | New Buy +100.00% | 75.00K | $813.75K | 0.34% 0.34ppt | 0.00% | 1 Quarter | Q1 2026 | |
15 ![]() QTTB | Pharmaceutical Pres | $3.44 | Cut -63.42% | 101.62K | $736.73K | 0.31% -0.08ppt | 0.83% | 6 Quarters | Q1 2026 | |
16 ![]() BOLT | Pharmaceutical Pres | $5.77 | 0.00% | 31.31K | $137.12K | 0.06% -0.02ppt | 1.67% | 4 Quarters | Q2 2025 | |
17 ![]() DNA | Biological products | $9.82 | 0.00% | 2.93K | $17.36K | 0.01% -0.00ppt | 0.01% | 6 Quarters | Q4 2024 | |
18 ![]() SENS | - | $10.47 | 0.00% | 2.17K | $14.24K | 0.01% 0.00ppt | 0.00% | 6 Quarters | Q4 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers